Clinical trial
Analyses of Human Samples Collected in Clinical Trials
NCT00339664
Study timeline
Study start (actual)2003-07-02Date precision: day
Registry last updated2020-03-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Leukemia, Myeloidunresolved
Neoplasm Metastasisunresolved
Leukemia, Lymphoidunresolved
Prostate Cancerunresolved
Interventions
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
BaltimoreMaryland, United States3RichmondVirginia, United States2ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1RochesterMinnesota, United States1CharlestonSouth Carolina, United States1BethesdaMaryland, United States1RotterdamNetherlands1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00339664 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.